{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:44:46Z","timestamp":1790253886605,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T00:00:00Z","timestamp":1586995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["CA211030"],"award-info":[{"award-number":["CA211030"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA098131"],"award-info":[{"award-number":["P50CA098131"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["MD007593"],"award-info":[{"award-number":["MD007593"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["MD007586"],"award-info":[{"award-number":["MD007586"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA163069"],"award-info":[{"award-number":["CA163069"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM059994"],"award-info":[{"award-number":["GM059994"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002243"],"award-info":[{"award-number":["UL1TR002243"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0231711","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T18:42:54Z","timestamp":1587062574000},"page":"e0231711","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets"],"prefix":"10.1371","volume":"15","author":[{"given":"Olga Y.","family":"Korolkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarrah E.","family":"Widatalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diva S.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys N.","family":"Nangami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeniyi","family":"Abimbola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather K.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-6538","authenticated-orcid":true,"given":"Emily","family":"Reisenbichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Kay","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Ochieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2283-794X","authenticated-orcid":true,"given":"Amos M.","family":"Sakwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,4,16]]},"reference":[{"issue":"2","key":"pone.0231711.ref001","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/modpathol.2010.200","article-title":"Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists","volume":"24","author":"S Badve","year":"2011","journal-title":"Mod Pathol"},{"issue":"21","key":"pone.0231711.ref002","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"LA Carey","year":"2006","journal-title":"Jama"},{"key":"pone.0231711.ref003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/CMAR.S146658","article-title":"Neoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going","volume":"10","author":"C Omarini","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"6","key":"pone.0231711.ref004","doi-asserted-by":"crossref","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","article-title":"Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection","volume":"11","author":"BD Lehmann","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"pone.0231711.ref005","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"MD Burstein","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"1","key":"pone.0231711.ref006","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13058-016-0690-8","article-title":"Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer","volume":"18","author":"YR Liu","year":"2016","journal-title":"Breast Cancer Res"},{"issue":"7","key":"pone.0231711.ref007","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"BD Lehmann","year":"2011","journal-title":"J Clin Invest"},{"issue":"11","key":"pone.0231711.ref008","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/gcc.20366","article-title":"Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer","volume":"45","author":"A Bergamaschi","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"pone.0231711.ref009","doi-asserted-by":"crossref","first-page":"860","DOI":"10.5858\/133.6.860","article-title":"Basal-like breast carcinoma: from expression profiling to routine practice","volume":"133","author":"E Rakha","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"pone.0231711.ref010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"S Liu","year":"2013","journal-title":"Stem cell reports"},{"issue":"10","key":"pone.0231711.ref011","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/stem.1752","article-title":"STAT3 Signaling Is Activated Preferentially in Tumor-Initiating Cells in Claudin-Low Models of Human Breast Cancer","volume":"32","author":"W Wei","year":"2014","journal-title":"STEM CELLS"},{"issue":"6","key":"pone.0231711.ref012","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.yexcr.2010.12.008","article-title":"Annexin A6 contributes to the invasiveness of breast carcinoma cells by influencing the organization and localization of functional focal adhesions","volume":"317","author":"AM Sakwe","year":"2011","journal-title":"Exp Cell Res"},{"issue":"5","key":"pone.0231711.ref013","first-page":"555","article-title":"Annexin A6 is down-regulated through promoter methylation in gastric cancer","volume":"5","author":"X Wang","year":"2013","journal-title":"Am J Transl Res"},{"issue":"17","key":"pone.0231711.ref014","first-page":"3855","article-title":"Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression","volume":"56","author":"G Francia","year":"1996","journal-title":"Cancer Res"},{"issue":"24","key":"pone.0231711.ref015","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/cncr.28963","article-title":"Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma","volume":"120","author":"AH Zaidi","year":"2014","journal-title":"Cancer"},{"issue":"4","key":"pone.0231711.ref016","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3892\/ol.2015.3498","article-title":"Role of annexin A6 in cancer","volume":"10","author":"H Qi","year":"2015","journal-title":"Oncol Lett"},{"issue":"2","key":"pone.0231711.ref017","doi-asserted-by":"crossref","first-page":"133","DOI":"10.18632\/oncotarget.26512","article-title":"Implication of calcium activated RasGRF2 in Annexin A6-mediated breast tumor cell growth and motility","volume":"10","author":"DS Whalen","year":"2019","journal-title":"Oncotarget"},{"issue":"7","key":"pone.0231711.ref018","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/ncb2271","article-title":"RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation","volume":"13","author":"F Calvo","year":"2011","journal-title":"Nat Cell Biol"},{"issue":"19","key":"pone.0231711.ref019","doi-asserted-by":"crossref","first-page":"13638","DOI":"10.1074\/jbc.M113.511360","article-title":"betaArrestin1 regulates the guanine nucleotide exchange factor RasGRF2 expression and the small GTPase Rac-mediated formation of membrane protrusion and cell motility","volume":"289","author":"X Ma","year":"2014","journal-title":"J Biol Chem"},{"issue":"18","key":"pone.0231711.ref020","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.2011.593","article-title":"A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer","volume":"305","author":"C Hatzis","year":"2011","journal-title":"Jama"},{"key":"pone.0231711.ref021","article-title":"ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients","author":"JT Fekete","year":"2019","journal-title":"Int J Cancer"},{"issue":"1","key":"pone.0231711.ref022","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1476-4598-12-167","article-title":"Reduced annexin A6 expression promotes the degradation of activated epidermal growth factor receptor and sensitizes invasive breast cancer cells to EGFR-targeted tyrosine kinase inhibitors","volume":"12","author":"RB Koumangoye","year":"2013","journal-title":"Mol Cancer"},{"issue":"Pt 2","key":"pone.0231711.ref023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1469-7793.1999.397ae.x","article-title":"Divalent cation permeability and blockade of Ca2+-permeant non-selective cation channels in rat adrenal zona glomerulosa cells","volume":"514","author":"DP Lotshaw","year":"1999","journal-title":"J Physiol"},{"issue":"4","key":"pone.0231711.ref024","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2016.10.002","article-title":"Two translation initiation codons direct the expression of annexin VI 64kDa and 68kDa isoforms","volume":"119","author":"A Gonzalez-Noriega","year":"2016","journal-title":"Mol Genet Metab"},{"issue":"3","key":"pone.0231711.ref025","doi-asserted-by":"crossref","first-page":"e60235","DOI":"10.1371\/journal.pone.0060235","article-title":"Non-selective calcium channel blocker bepridil decreases secondary pathology in mice after photothrombotic cortical lesion","volume":"8","author":"A Lipsanen","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"pone.0231711.ref026","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.HYP.37.5.1268","article-title":"Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model","volume":"37","author":"KA Griffin","year":"2001","journal-title":"Hypertension"},{"issue":"3","key":"pone.0231711.ref027","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"B Gyorffy","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"pone.0231711.ref028","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"10","key":"pone.0231711.ref029","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/annonc\/mdu247","article-title":"Activated PI3K\/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer","volume":"25","author":"K Hashimoto","year":"2014","journal-title":"Ann Oncol"},{"issue":"22","key":"pone.0231711.ref030","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"M Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"pone.0231711.ref031","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/annonc\/mdq700","article-title":"Relationship between estrogen receptor, progesterone receptor, HER-2 and Ki67 expression and efficacy of aromatase inhibitors in advanced breast cancer","volume":"22","author":"H Anderson","year":"2011","journal-title":"Ann Oncol"},{"issue":"4","key":"pone.0231711.ref032","doi-asserted-by":"crossref","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","article-title":"Ki-67 as a prognostic marker according to breast cancer molecular subtype","volume":"13","author":"NA Soliman","year":"2016","journal-title":"Cancer Biol Med"},{"issue":"6","key":"pone.0231711.ref033","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/MCB.21.6.2107-2117.2001","article-title":"Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2","volume":"21","author":"CL de Hoog","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"24","key":"pone.0231711.ref034","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.1158\/0008-5472.CAN-07-2687","article-title":"Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells","volume":"67","author":"FV Jacinto","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"pone.0231711.ref035","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/0008-5472.CAN-14-2391","article-title":"Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer","volume":"76","author":"NJ Raynal","year":"2016","journal-title":"Cancer Res"},{"issue":"8","key":"pone.0231711.ref036","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/carcin\/bgy192","article-title":"Lapatinib-induced annexin A6 upregulation as an adaptive response of triple-negative breast cancer cells to EGFR tyrosine kinase inhibitors","volume":"40","author":"SE Widatalla","year":"2019","journal-title":"Carcinogenesis"},{"issue":"22","key":"pone.0231711.ref037","doi-asserted-by":"crossref","first-page":"16059","DOI":"10.18632\/oncotarget.24685","article-title":"Store operated calcium entry is altered by the inhibition of receptors tyrosine kinase","volume":"9","author":"N Emeriau","year":"2018","journal-title":"Oncotarget"},{"issue":"7","key":"pone.0231711.ref038","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1182\/blood.V97.7.2115","article-title":"Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia","volume":"97","author":"JS Chen","year":"2001","journal-title":"Blood"},{"issue":"1","key":"pone.0231711.ref039","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s40064-016-2444-6","article-title":"Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women","volume":"5","author":"S Prasad","year":"2016","journal-title":"Springerplus"},{"issue":"2","key":"pone.0231711.ref040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10549-013-2560-8","article-title":"Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry","volume":"139","author":"EC Inwald","year":"2013","journal-title":"Breast cancer research and treatment"},{"issue":"8","key":"pone.0231711.ref041","first-page":"1609","article-title":"A perspective on anti-EGFR therapies targeting triple-negative breast cancer","volume":"6","author":"K Nakai","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"5","key":"pone.0231711.ref042","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/acs.molpharmaceut.6b00952","article-title":"Targeted Covalent Inhibition of Grb2-Sos1 Interaction through Proximity-Induced Conjugation in Breast Cancer Cells","volume":"14","author":"Y Yu","year":"2017","journal-title":"Mol Pharm"},{"key":"pone.0231711.ref043","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-0-387-69080-3_1","article-title":"Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy","volume":"617","author":"B Weinstein","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"pone.0231711.ref044","doi-asserted-by":"crossref","first-page":"e71915","DOI":"10.1371\/journal.pone.0071915","article-title":"Molecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapy","volume":"8","author":"R Lindner","year":"2013","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T05:54:20Z","timestamp":1615269260000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0231711"}},"subtitle":[],"editor":[{"given":"Sushanta K.","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,4,16]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0231711","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,16]]}}}